Sungjune Kim

H. Lee Moffitt Cancer Ctr & Res Inst

$2,641,607

Attributed

$2,641,607

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $376.8K · FY2016–25

$500K$375K$250K$125K$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,641,607 · 2

By mechanism

R37$1,820,807 · 1

K08$820,800 · 1

Top collaborators

No co-investigators on record.

Most similar at H. Lee Moffitt Cancer Ctr & Res Inst

Same institution · by research overlap

Inna Smalley$1,373,060
Keiran Smalley$7,060,803
Jianguo Tao$3,452,402
Frederick Locke$1,743,048
Shari Pilon-Thomas$5,168,533

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsImmunotherapyResponseMediatingT-LymphocyteTumor MicroenvironmentResistanceImmunologicsMolecularMelanomaSamplingSignal TransductionTreatment EfficacyTumorImmuneCancer ImmunotherapyCancer PatientCancer TherapyIn VivoUp-RegulationImmunoregulationImmune FunctionImmune ResponseEnzymes